Evaluation of cfDNA as an early detection assay for dense tissue breast cancer.
Ontology highlight
ABSTRACT: A cell-free DNA (cfDNA) assay would be a promising approach to early cancer diagnosis, especially for patients with dense tissues. Consistent cfDNA signatures have been observed for many carcinogens. Recently, investigations of cfDNA as a reliable early detection bioassay have presented a powerful opportunity for detecting dense tissue screening complications early. We performed a prospective study to evaluate the potential of characterizing cfDNA as a central element in the early detection of dense tissue breast cancer (BC). Plasma samples were collected from 32 consenting subjects with dense tissue and positive mammograms, 20 with positive biopsies and 12 with negative biopsies. After screening and before biopsy, cfDNA was extracted, and whole-genome next-generation sequencing (NGS) was
SUBMITTER: Barbirou M
PROVIDER: S-EPMC9120463 | biostudies-literature | 2022 May
REPOSITORIES: biostudies-literature
ACCESS DATA